NCT00110500View on ClinicalTrials.gov

Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Diabetic Neuropathy
Interventions
GENETIC

hVEGF-A

Trial Locations (1)

78229-4801

San Antonio

Sponsors
All Listed Sponsors
lead

Sangamo Therapeutics

INDUSTRY